Skip to content
  • Sunday, 26 July 2026
  • 4:38 am
  • Follow Us
Lab DB
  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ
  • Home
  • Apotex Acquires Cumberland Pharmaceuticals’ Branded Drug Portfolio for $100 Million, Ushering in New Era for Both Companies
Pharmaceutical R&D

Apotex Acquires Cumberland Pharmaceuticals’ Branded Drug Portfolio for $100 Million, Ushering in New Era for Both Companies

Teuku Ryan Apr 26, 2026 0

Canadian pharmaceutical giant Apotex has announced a significant strategic acquisition, agreeing to purchase Cumberland Pharmaceuticals’ entire portfolio of branded commercial…

Read More
Pharmaceutical R&D

Biogen Secures Global Rights to TJ Biopharma’s Felzartamab in Landmark $850 Million Deal, Aiming to Disrupt Multiple Myeloma Treatment Landscape

Teuku Ryan Apr 25, 2026 0

Biogen announced on April 20, 2026, a significant strategic acquisition, securing exclusive rights to TJ Biopharma’s novel anti-CD38 immunotherapy, felzartamab,…

Read More
Molecular & Cell Biology

The Ancient Story of Every Breath You Take: 289-Million-Year-Old Fossil Reveals Earliest Rib-Based Breathing System in Amniotes

Angie Faith Apr 23, 2026 0

The seemingly mundane act of taking a breath, a process so fundamental to life that it often goes unnoticed, is…

Read More
Pharmaceutical R&D

Ray Therapeutics Secures $125 Million Series B Funding to Accelerate Vision Restoration Pipeline

Teuku Ryan Apr 22, 2026 0

Ray Therapeutics, a biopharmaceutical company at the forefront of developing novel gene therapies for vision restoration, has successfully closed a…

Read More
Molecular & Cell Biology

This crocodile ran like a greyhound across prehistoric Britain 200 million years ago

Angie Faith Apr 19, 2026 0

The ancient landscape of what is now Gloucester, UK, once teemed with a remarkable array of prehistoric life, and a…

Read More
Pharmaceutical R&D

Kailera Therapeutics Secures $625 Million in Landmark IPO to Accelerate Obesity Drug Development

Teuku Ryan Apr 17, 2026 0

Obesity-focused biotechnology firm Kailera Therapeutics has successfully launched its Initial Public Offering (IPO), raising an impressive $625 million. This significant…

Read More
Pharmaceutical R&D

Terremoto Biosciences Secures $108 Million Series C to Advance Next-Generation AKT1 Inhibitors for Oncology and Rare Diseases

Teuku Ryan Apr 16, 2026 0

Terremoto Biosciences, a pioneering biotechnology company at the forefront of developing novel therapeutics targeting the PI3K/AKT pathway, announced today the…

Read More
Environmental & Analytical Chemistry

The Over 300-Million-Year-Old Pohlsepia May Be a Nautilus Called Paleocadmus

Abdurrohim Arsyad Apr 15, 2026 0

Paleontologists have unveiled a groundbreaking reclassification of a fossil previously identified as Pohlsepia, a purported ancient octopus. New research suggests…

Read More
Pharmaceutical R&D

AbbVie Secures Up to $745 Million in Pain Pipeline Deal with Chinese Biopharma Haisco

Teuku Ryan Apr 13, 2026 0

AbbVie, a global biopharmaceutical giant, has finalized a significant strategic collaboration with Haisco Pharmaceutical Group, a prominent Chinese biopharmaceutical company.…

Read More
Molecular & Cell Biology

This crocodile ran like a greyhound across prehistoric Britain 200 million years ago

Angie Faith Apr 12, 2026 0

Scientists have unearthed a remarkable new species of ancient crocodile relative, unearthed from the fossil-rich deposits of Gloucester, United Kingdom.…

Read More

Posts pagination

1 2 3 4 5
Science News: A Century of Empowering Public Understanding of ScienceThe Humble Dropping That Fueled an Empire: Seabird Guano Revolutionized Ancient Peruvian Agriculture and Propelled the Chincha Kingdom to ProminenceCEO of CDMO AustinPx on its exclusive agreement with Thermo Fisher’s Patheon divisionCornell University Scientists Develop Breakthrough Reversible Nonhormonal Male Contraceptive Through Targeted Meiotic Disruption
MEDVi Under Scrutiny: AI-Powered Telehealth Startup Faces FDA Warnings, Deceptive Marketing Allegations, and Multiple Lawsuits Despite Meteoric GrowthLLMOps in 2026: The 10 Tools Every Team Must HaveJapan’s FY26 NHI Drug Price Revision: Deeper Dive into Mechanisms and Market ImpactThe Most Favored Nation (MFN) Policy’s Unforeseen Ripple Effect: European Pharmaceutical Launches and Withdrawals Plummet
Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’sKing’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286Living Plastics That Self-Destruct: Scientists Engineer Microbe-Embedded Polymers for Complete and Rapid DecompositionSanofi Discontinues Amlitelimab Development in Atopic Dermatitis, Citing Lack of Meaningful Differentiation
YOU MAY HAVE MISSED
Laboratory Automation & Robotics
Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’s
Lana Keisha Jul 25, 2026
Neuroscience & Brain Research
King’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286
Rifan Muazin Jul 25, 2026
Advanced Materials Science
Living Plastics That Self-Destruct: Scientists Engineer Microbe-Embedded Polymers for Complete and Rapid Decomposition
Nila Kartika Wati Jul 25, 2026
Pharmaceutical R&D
Sanofi Discontinues Amlitelimab Development in Atopic Dermatitis, Citing Lack of Meaningful Differentiation
Teuku Ryan Jul 25, 2026

Copyright © 2025 | Powered by WordPress | News Gadgets by ThemeArile

  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ